Effect of Extensive Ablation on Recurrence in Patients with Persistent Atrial Fibrillation Treated with Pulmonary Vein Isolation (EARNEST-PVI) trial: Design and rationale.
CONCLUSIONS: The EARNEST-PVI trial is a randomized controlled trial designed to assess whether PVI alone is non-inferior to extended substrate ablation for patients with persistent AF undergoing a first catheter ablation.
PMID: 30853354 [PubMed - as supplied by publisher]
Source: Journal of Cardiology - Category: Cardiology Authors: Dohi T, Nakatani D, Inoue K, Hikoso S, Oka T, Hayashi K, Masuda M, Furukawa Y, Kawasaki M, Egami Y, Kashiwase K, Hirata A, Watanabe T, Miyoshi M, Takeda T, Nakagawa A, Mizuno H, Minamiguchi H, Kitamura T, Suna S, Kojima T, Kida H, Bolrathanak O, Okuyama Y Tags: J Cardiol Source Type: research
More News: Atrial Fibrillation | Cardiology | Cardiovascular | Conferences | Electrocardiogram | Heart | Science | Stroke | Study